Liverpool New Models for Clinical Evaluation
Development of new clinical models of diseases that can then be used to develop new vaccines, antibiotics and other therapeutic interventions.
Liverpool Antimicrobial Reactor (LAR)
A global hub for antimicrobial drug (traditional and non-traditional) and vaccine development.
Development of new antimicrobial materials and surfaces to prevent the transmission of infection and impact of infection in clinical settings.
Liverpool Adaptive Diagnostic Platform (LADP)
An engine for the development of new diagnostic approaches to facilitate the precise use of antimicrobial agents.
Liverpool Deep Phenotyping
Quantification of the differential responses and safety profiles of antimicrobial agents and vaccines in various patient subgroups.
Liverpool Precision Dosing Unit (LPDU)
Advanced PK-PD studies of newly licenced drugs in “real world” settings.
Smart Antimicrobial System (SAS)
Building on the Combined Intelligence for Public Health Action (CIPHA) data, digital infrastructure and operational networks to use antibiotics at a system level.
Infection Systems Simulator (iSIM)
Use of simulation to predict outcomes of a wide range of infection interventions.
Emergence Surveillance and Preparedness (ESP)
Combining key expertise to address antimicrobial challenges posed by non-zoonotic emerging infections and AMR.